{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alkaloids", "Amaryllidaceae", "Benign prostatic hyperplasia (BPH)", "Bioactive markers", "Crinum latifolium", "Standardization"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35585532", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "20"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "18"}], "Language": ["eng"], "ELocationID": ["139", "10.1186/s12906-022-03617-x"], "Journal": {"ISSN": "2662-7671", "JournalIssue": {"Volume": "22", "Issue": "1", "PubDate": {"Year": "2022", "Month": "May", "Day": "18"}}, "Title": "BMC complementary medicine and therapies", "ISOAbbreviation": "BMC Complement Med Ther"}, "ArticleTitle": "Standardization of the ethanolic extract of Crinum latifolium leaves by two bioactive markers with antiproliferative activity against TGF-\u03b2-promoted prostate stromal cells (WPMY-1).", "Pagination": {"StartPage": "139", "MedlinePgn": "139"}, "Abstract": {"AbstractText": ["Crinum latifolium L. (Amaryllidaceae) has been used in Southeast Asian traditional medicine to alleviate the symptoms of benign prostatic hyperplasia (BPH). The pathological mechanism of BPH is associated with the induction of prostate stromal cell proliferation through transforming growth factor-beta (TGF-\u03b2). Standardization as well as investigation of the potential anti-BPH activity of C. latifolium extract could benefit the further development of BPH-related analyses and provide evidence to support the application of this extract for BPH treatment. This study aimed to standardize and investigate the antiproliferative activity of the ethanolic extract of C. latifolium leaves. The major alkaloids isolated from C. latifolium were also explored for their potential use as bioactive markers.", "Two major alkaloids were isolated from the ethanolic extract of C. latifolium leaves by chromatographic techniques, identified by NMR and MS, and quantified by a validated UHPLC method. Their antiproliferative activity was studied in human prostate stromal cells (WPMY-1) induced by TGF-\u03b2. The synergistic effect of combining the two major isolated alkaloids was analyzed by the zero interaction potency (ZIP) model.", "Two alkaloids, lycorine (1) and 6\u03b1-hydroxybuphanidrine (2), were isolated from the ethanolic leaf extract of C. latifolium. A UHPLC method for the quantification of (1) and (2) was developed and validated in terms of linearity, precision, and accuracy. The C. latifolium leaf extract contained 0.279\u2009\u00b1\u20090.003% (1) and 0.232\u2009\u00b1\u20090.004% (2). The crude extract was more potent than either (1) and (2) alone against TGF-\u03b2-treated WPMY-1 cell proliferation. The drug combination study revealed that the greatest synergistic effect of (1) and (2) was achieved at a 1:1 ratio.", "The results of this study support the anti-BPH activity of C. latifolium in traditional medicine and suggest that these the two isolated alkaloids may promote the efficacy of the C. latifolium extract. Additionally, major alkaloids (1) and (2) can be used as bioactive markers for the standardization of C. latifolium extracts."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Excellence in DNA Barcoding of Thai Medicinal Plants, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand."}], "LastName": "Thongphichai", "ForeName": "Wisuwat", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Excellence in DNA Barcoding of Thai Medicinal Plants, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand."}], "LastName": "Uttarawichien", "ForeName": "Tamonwan", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand."}, {"Identifier": [], "Affiliation": "Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand."}], "LastName": "Chanvorachote", "ForeName": "Pithi", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chao Phya Abhaibhubejhr Hospital Foundation, Prachinburi, 25000, Thailand."}], "LastName": "Pitiporn", "ForeName": "Supaporn", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Innovation and Product Development Center, SCG Packaging Company Ltd, Ratchaburi, 70110, Thailand."}], "LastName": "Charoen-Ame", "ForeName": "Todsaphol", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chao Phya Abhaibhubejhr Hospital Foundation, Prachinburi, 25000, Thailand."}], "LastName": "Kwankhao", "ForeName": "Pakakrong", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand."}], "LastName": "Towiwat", "ForeName": "Pasarapa", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Excellence in DNA Barcoding of Thai Medicinal Plants, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. suchada.su@chula.ac.th."}], "LastName": "Sukrong", "ForeName": "Suchada", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Med Ther", "NlmUniqueID": "101761232", "ISSNLinking": "2662-7671"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["chemistry"], "DescriptorName": "Crinum"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["pathology"], "DescriptorName": "Prostate"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Prostatic Hyperplasia"}, {"QualifierName": [], "DescriptorName": "Reference Standards"}, {"QualifierName": ["pathology"], "DescriptorName": "Stromal Cells"}, {"QualifierName": [], "DescriptorName": "Transforming Growth Factor beta"}], "CoiStatement": "The authors report there are no competing interests to declare."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Urology Care Foundation. Benign prostatic hyperplasia (BPH). 2021. https://www.urologyhealth.org/urology-a-z/b/benign-prostatic-hyperplasia-(bph). Accessed 21 Jan 2022."}, {"Citation": "Ng M, Baradhi KM. Benign Prostatic Hyperplasia. In: StatPearls [Internet].\u00a0Treasure Island: StarPearls Publishing; 2021.\u00a0[cited 2022 February 4]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558920/."}, {"Citation": "Foo KT. What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)? World J Urol. 2019;37:1293\u20131296. doi: 10.1007/s00345-019-02691-0.", "ArticleIdList": ["10.1007/s00345-019-02691-0", "PMC6620380", "30805683"]}, {"Citation": "Kim EH, Larson JA, Andriole GL. Management of benign prostatic hyperplasia. Annu Rev Med. 2016;67:137\u2013151. doi: 10.1146/annurev-med-063014-123902.", "ArticleIdList": ["10.1146/annurev-med-063014-123902", "26331999"]}, {"Citation": "Banerjee PP, Banerjee S, Brown TR, Zirkin BR. Androgen action in prostate function and disease. Am J Clin Exp Urol. 2018;6:62\u201377.", "ArticleIdList": ["PMC5902724", "29666834"]}, {"Citation": "Ho CK, Habib FK. Estrogen and androgen signaling in the pathogenesis of BPH. Nat Rev Urol. 2011;8:29\u201341. doi: 10.1038/nrurol.2010.207.", "ArticleIdList": ["10.1038/nrurol.2010.207", "21228820"]}, {"Citation": "Huang X, Lee C. Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta. Front Biosci. 2003;8:s740\u2013s749. doi: 10.2741/1017.", "ArticleIdList": ["10.2741/1017", "12957826"]}, {"Citation": "la Shareef Z, Kardooni H, Murillo-Garzon V, Domenici G, Stylianakis E, Steel JH, et al. Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1. Oncogene. 2018;37:5305\u201324. doi: 10.1038/s41388-018-0294-0.", "ArticleIdList": ["10.1038/s41388-018-0294-0", "PMC6160402", "29858602"]}, {"Citation": "Claus S, Wrenger M, Senge T, Schulze H. Immunohistochemical determination of age related proliferation rates in normal and benign hyperplastic human prostates. Urol Res. 1993;21:305\u2013308. doi: 10.1007/BF00296825.", "ArticleIdList": ["10.1007/BF00296825", "7506462"]}, {"Citation": "Elkelany OO, Owen RC, Kim ED. Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus. Ther Clin Risk Manag. 2015;11:507\u2013513. doi: 10.2147/TCRM.S80353.", "ArticleIdList": ["10.2147/TCRM.S80353", "PMC4386768", "25848297"]}, {"Citation": "Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I-initial work-up and medical management. J Urol. 2021;206:806\u2013817. doi: 10.1097/JU.0000000000002183.", "ArticleIdList": ["10.1097/JU.0000000000002183", "34384237"]}, {"Citation": "Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part II-surgical evaluation and treatment. J Urol. 2021;206:818\u2013826. doi: 10.1097/JU.0000000000002184.", "ArticleIdList": ["10.1097/JU.0000000000002184", "34384236"]}, {"Citation": "World Checklist of Selected Plant Families (WCSP). London (UK): Royal Botanic Gardens, Kew. http://wcsp.science.kew.org. Accessed 14 Dec 2021."}, {"Citation": "Zvetkova E, Wirleitner B, Tram NT, Schennach H, Fuchs D. Aqueous extracts of Crinum latifolium (L.) and Camellia sinensis show immunomodulatory properties in human peripheral blood mononuclear cells. Int Immunopharmacol. 2001;1:2143\u201350. doi: 10.1016/S1567-5769(01)00140-0.", "ArticleIdList": ["10.1016/S1567-5769(01)00140-0", "11710543"]}, {"Citation": "Pitiporn S. Wan Raeng Kho Kham [Crinum latifolium] In: Pitiporn S, editor. Banthuek Khong Phaendin 10 Samunphrai Phuea Sukkhaphap\u2026Phu Bao Phoruean [Record of the land 10: herbs for men] Bangkok: Chao Phya Abhaibhubejhr Hospital Foundation under patronage of Princess Bejaratana Rajasuda; 2017. pp. 111\u2013115."}, {"Citation": "Nguyen HY, Vo BH, Nguyen LT, Bernad J, Alaeddine M, Coste A, et al. Extracts of Crinum latifolium inhibit the cell viability of mouse lymphoma cell line EL4 and induce activation of anti-tumour activity of macrophages in vitro. J Ethnopharmacol. 2013;149:75\u201383. doi: 10.1016/j.jep.2013.06.002.", "ArticleIdList": ["10.1016/j.jep.2013.06.002", "23769983"]}, {"Citation": "Jenny M, Wondrak A, Zvetkova E, Tram NT, Phi PT, Schennach H, et al. Crinum latifolium leave extracts suppress immune activation cascades in peripheral blood mononuclear cells and proliferation of prostate tumor cells. Sci Pharm. 2011;79:323\u2013335. doi: 10.3797/scipharm.1011-13.", "ArticleIdList": ["10.3797/scipharm.1011-13", "PMC3134856", "21773069"]}, {"Citation": "Boshra YR, Fahim JR, Hamed ANE, Desoukey SY. Phytochemical and biological attributes of Narcissus pseudonarcissus L. (Amaryllidaceae): a review. S Afr J Bot. 2022;146:437\u201358. doi: 10.1016/j.sajb.2021.11.028.", "ArticleIdList": ["10.1016/j.sajb.2021.11.028"]}, {"Citation": "Slabaugh MR, Wildman WC. 6-Hydroxybuphanidrine and 6-Hydroxypowelline. J Org Chem. 1971;36:3202\u20133207. doi: 10.1021/jo00820a027.", "ArticleIdList": ["10.1021/jo00820a027"]}, {"Citation": "Roy M, Liang L, Xiao X, Feng P, Ye Mao, Liu J. Lycorine: a prospective natural lead for anticancer drug discovery. Biomed Pharmacother. 2018;107:615\u201324. doi: 10.1016/j.biopha.2018.07.147.", "ArticleIdList": ["10.1016/j.biopha.2018.07.147", "PMC7127747", "30114645"]}, {"Citation": "Jahan N, Chowdhury A, Li T, Xu K, Wei F, Wang S. Neferine improves oxidative stress and apoptosis in benign prostate hyperplasia via Nrf2-ARE pathway. Redox Rep. 2021;26:1\u20139. doi: 10.1080/13510002.2021.1871814.", "ArticleIdList": ["10.1080/13510002.2021.1871814", "PMC7808392", "33416009"]}, {"Citation": "Wang S, Lee DY, Shang Y, Liao J, Cao X, Xie L, et al. The bioactive alkaloids identified from Cortex Phellodendri ameliorate benign prostatic hyperplasia via LOX-5/COX-2 pathways. Phytomedicine. 2021;93:153813. doi: 10.1016/j.phymed.2021.153813.", "ArticleIdList": ["10.1016/j.phymed.2021.153813", "34735909"]}, {"Citation": "Liu J, Fang T, Li M, Song Y, Li J, Xue Z, et al. Pao Pereira extract attenuates testosterone-induced benign prostatic hyperplasia in rats by inhibiting 5alpha-reductase. Sci Rep. 2019;9:19703. doi: 10.1038/s41598-019-56145-z.", "ArticleIdList": ["10.1038/s41598-019-56145-z", "PMC6928012", "31873149"]}, {"Citation": "Efferth T, Koch E, Complex interactions between phytochemicals The multi-target therapeutic concept of phytotherapy. Curr Drug Targets. 2011;12:122\u201332. doi: 10.2174/138945011793591626.", "ArticleIdList": ["10.2174/138945011793591626", "20735354"]}, {"Citation": "Rasoanaivo P, Wright CW, Willcox ML, Gilbert B. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malar J. 2011;10(Suppl 1):S4. doi: 10.1186/1475-2875-10-S1-S4.", "ArticleIdList": ["10.1186/1475-2875-10-S1-S4", "PMC3059462", "21411015"]}, {"Citation": "Bilia AR. Science meets regulation. J Ethnopharmacol. 2014;158 PART B:487\u201394. doi: 10.1016/j.jep.2014.06.036.", "ArticleIdList": ["10.1016/j.jep.2014.06.036", "25017375"]}, {"Citation": "Li S, Han Q, Qiao C, Song J, Lung Cheng C, Xu H. Chemical markers for the quality control of herbal medicines: an overview. Chin Med. 2008;3:7. doi: 10.1186/1749-8546-3-7.", "ArticleIdList": ["10.1186/1749-8546-3-7", "PMC2488332", "18588699"]}, {"Citation": "Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, et al. Cell Viability Assays. In: Assay Guidance Manual [Internet].\u00a0Bethesda: Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2016. [cited 2022 April 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK144065/."}, {"Citation": "Ianevski A, He L, Aittokallio T, Tang J. SynergyFinder: a web application for analyzing drug combination dose-response matrix data. Bioinformatics. 2017;33:2413\u20132415. doi: 10.1093/bioinformatics/btx162.", "ArticleIdList": ["10.1093/bioinformatics/btx162", "PMC5554616", "28379339"]}, {"Citation": "Yamada K, Yamashita M, Sumiyoshi T, Nishimura K, Tomioka K. Total synthesis of (-)-lycorine and (-)-2-epi-lycorine by asymmetric conjugate addition cascade. Org Lett. 2009;11:1631\u20131633. doi: 10.1021/ol9003564.", "ArticleIdList": ["10.1021/ol9003564", "19243131"]}, {"Citation": "Nair JJ, Campbell WE, Brun R, Viladomat F, Codina C, Bastida J. Alkaloids from Nerine filifolia. Phytochemistry. 2005;66:373\u2013382. doi: 10.1016/j.phytochem.2004.12.009.", "ArticleIdList": ["10.1016/j.phytochem.2004.12.009", "15680994"]}, {"Citation": "Hotchandani T, de Villers J, Desgagne-Penix I. Developmental regulation of the expression of Amaryllidaceae alkaloid biosynthetic genes in Narcissus papyraceus. Genes (Basel) 2019;10:594. doi: 10.3390/genes10080594.", "ArticleIdList": ["10.3390/genes10080594", "PMC6723416", "31394782"]}, {"Citation": "Gray AL, Stephens CA, Bigelow RLH, Coleman DT, Cardelli JA. The polyphenols (-)-epigallocatechin-3-gallate and luteolin synergistically inhibit TGF-\u03b2-induced myofibroblast phenotypes through rhoa and ERK inhibition. PLoS One. 2014;9:e109208. doi: 10.1371/journal.pone.0109208.", "ArticleIdList": ["10.1371/journal.pone.0109208", "PMC4182889", "25272043"]}, {"Citation": "Nikam PH, Kareparamban J, Jadhav A, Kadam V. Future trends in standardization of herbal drugs. J Appl Pharm Sci. 2012;2:38\u201344."}, {"Citation": "Refaat J, Kamel MS, Ramadan MA, Ali AA. Crinum; an endless source of bioactive principles: a review. part 1- Crinum alkaloids: lycorine-type alkaloids. Int J Pharm Sci Res. 2012;3:1883\u201390."}, {"Citation": "White NJ. Qinghaosu (artemisinin): the price of success. Science. 2008;320:330\u2013334. doi: 10.1126/science.1155165.", "ArticleIdList": ["10.1126/science.1155165", "18420924"]}, {"Citation": "Elford BC, Roberts MF, Phillipson JD, Wilson RJ. Potentiation of the antimalarial activity of qinghaosu by methoxylated flavones. Trans R Soc Trop Med Hyg. 1987;81:434\u2013436. doi: 10.1016/0035-9203(87)90161-1.", "ArticleIdList": ["10.1016/0035-9203(87)90161-1", "3318019"]}, {"Citation": "Liu KC, Yang SL, Roberts MF, Elford BC, Phillipson JD. Antimalarial activity of Artemisia annua flavonoids from whole plants and cell cultures. Plant Cell Rep. 1992;11:637\u2013640. doi: 10.1007/BF00236389.", "ArticleIdList": ["10.1007/BF00236389", "24213368"]}, {"Citation": "Suberu JO, Gorka AP, Jacobs L, Roepe PD, Sullivan N, Barker GC, et al. Anti-plasmodial polyvalent interactions in Artemisia annua L. aqueous extract\u2013possible synergistic and resistance mechanisms. PLoS One. 2013;8:e80790. doi: 10.1371/journal.pone.0080790.", "ArticleIdList": ["10.1371/journal.pone.0080790", "PMC3828274", "24244716"]}, {"Citation": "Proksch A, Wagner H. Structural analysis of a 4-O-methyl-glucuronoarabinoxylan with immuno-stimulating activity from Echinacea purpurea. Phytochemistry. 1987;26:1989\u20131993. doi: 10.1016/S0031-9422(00)81744-6.", "ArticleIdList": ["10.1016/S0031-9422(00)81744-6"]}, {"Citation": "Todd DA, Gulledge Tv, Britton ER, Oberhofer M, Leyte-Lugo M, Moody AN, et al. Ethanolic Echinacea purpurea extracts contain a mixture of cytokine-suppressive and cytokine-inducing compounds, including some that originate from endophytic bacteria. PLoS One. 2015;10:e0124276. doi: 10.1371/journal.pone.0124276.", "ArticleIdList": ["10.1371/journal.pone.0124276", "PMC4416932", "25933416"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "11"}, {"Year": "2022", "Month": "5", "Day": "9"}, {"Year": "2022", "Month": "5", "Day": "18", "Hour": "23", "Minute": "39"}, {"Year": "2022", "Month": "5", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["35585532", "PMC9118764", "10.1186/s12906-022-03617-x", "10.1186/s12906-022-03617-x"]}}], "PubmedBookArticle": []}